論文

査読有り 筆頭著者
2019年1月

Retrograde superselective intra-arterial chemoradiotherapy combined with hyperthermia and cetuximab for carcinoma of the buccal mucosa with N3 lymph node metastasis: a case report.

Oral radiology
  • Kaname Sakuma
  • Toshiyuki Koizumi
  • Kenji Mitsudo
  • Jun Ueda
  • Yuichiro Hayashi
  • Toshinori Iwai
  • Makoto Hirota
  • Mitomu Kioi
  • Haruka Yoshii
  • Hisashi Kaizu
  • Masaharu Hata
  • Akira Tanaka
  • Iwai Tohnai
  • 全て表示

35
1
開始ページ
77
終了ページ
83
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1007/s11282-018-0319-y

We herein report a case of squamous cell carcinoma of the buccal mucosa with N3 cervical lymph node metastasis in a 63-year-old man. The patient was treated with combination therapy comprising radiotherapy (2 Gy/day, total of 70 Gy), superselective intra-arterial chemotherapy via a superficial temporal artery (docetaxel, total of 70 mg/m2 and cisplatin, total of 175 mg/m2), cetuximab (initial dose of 400 mg/m2 with subsequent weekly doses of 250 mg/m2 intravenously), and four sessions of hyperthermia for cervical lymph node metastases. The patient responded well to the therapy, with a complete response of the primary tumor. Radical neck dissection was performed with reconstructive surgery, including resection of the overlying skin. A pathologic complete response was achieved for the N3 and all other cervical lymph node metastases. The patient showed no evidence of recurrence in the 3 years following treatment. Based on the findings in the present case, the use of retrograde superselective intra-arterial chemoradiotherapy combined with hyperthermia and cetuximab seems to be a promising modality for patients with N3 cervical lymph node metastasis of oral cancer.

リンク情報
DOI
https://doi.org/10.1007/s11282-018-0319-y
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/30484180
URL
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85045149057&origin=inward
ID情報
  • DOI : 10.1007/s11282-018-0319-y
  • ISSN : 0911-6028
  • PubMed ID : 30484180
  • SCOPUS ID : 85045149057

エクスポート
BibTeX RIS